While peripheral insulin resistance is common during obesity in rodents and people, its progression to T2D is largely due to insulin secretory dysfunction and significant apoptosis of functional β-cells [4–8], leading to an inability to compensate for insulin resistance. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.